Literature DB >> 11844812

Novel artificial neural network for early detection of prostate cancer.

Bob Djavan1, Mesut Remzi, Alexandre Zlotta, Christian Seitz, Peter Snow, Michael Marberger.   

Abstract

PURPOSE: Two artificial neural networks (ANN) for the early detection of prostate cancer in men with total prostate-specific antigen (PSA) levels from 2.5 to 4 ng/mL and from 4 to 10 ng/mL were prospectively developed. The predictive accuracy of the ANN was compared with that obtained by use of conventional statistical analysis of standard PSA parameters. PATIENTS AND METHODS: Consecutive men with a serum total PSA level between 4 and 10 ng/mL (n = 974) and between 2.5 and 4 ng/mL (n = 272) were analyzed. A separate ANN model was developed for each group of patients. Analyses were performed to determine the presence of prostate cancer.
RESULTS: The area under the receiver operator characteristic (ROC) curve (AUC) was 87.6% and 91.3% for the 2.5 to 4 ng/mL and 4 to 10 ng/mL ANN models, respectively. For the latter model, the AUC generated by the ANN was significantly higher than that produced by the single variables of total PSA, percentage of free PSA, PSA density of the transition zone (TZ), and TZ volume (P <.01), but not significantly higher compared with multivariate analysis. For the 2.5 to 4 ng/mL model, the AUC of the ANN ROC curve was significantly higher than the AUCs for percentage of free PSA (P =.0239), PSA-TZ (P =.0204), and PSA density and total prostate volume (P <.01 for both).
CONCLUSION: The predictive accuracy of the ANN was superior to that of conventional PSA parameters. ANN models might change the way patients referred for early prostate cancer detection are counseled regarding the need for prostate biopsy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11844812     DOI: 10.1200/JCO.2002.20.4.921

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  30 in total

Review 1.  Finding biomarkers is getting easier.

Authors:  Brian Patrick Bradley
Journal:  Ecotoxicology       Date:  2012-03-13       Impact factor: 2.823

2.  Artificial neural networks for decision-making in urologic oncology.

Authors:  Theodore Anagnostou; Mesut Remzi; Bob Djavan
Journal:  Rev Urol       Date:  2003

3.  Diagnostic efficacy of free to total ratio of prostate-specific antigen and prostate-specific antigen velocity, singly and in combination, in detecting prostate cancer in patients with total serum prostate-specific antigen between 4 and 10 ng/ml.

Authors:  Shingo Yamamoto; Takuo Maruyama; Nobuyuki Kondoh; Michio Nojima; Hidekazu Takiuchi; Seiichi Hirota; Hiroki Shima
Journal:  Int Urol Nephrol       Date:  2007-07-06       Impact factor: 2.370

4.  Using biopsy to detect prostate cancer.

Authors:  Shahrokh F Shariat; Claus G Roehrborn
Journal:  Rev Urol       Date:  2008

5.  The value of an artificial neural network in the decision-making for prostate biopsies.

Authors:  R P Meijer; E F A Gemen; I E W van Onna; J C van der Linden; H P Beerlage; G C M Kusters
Journal:  World J Urol       Date:  2009-06-28       Impact factor: 4.226

6.  Chinese nomogram to predict probability of positive initial prostate biopsy: a study in Taiwan region.

Authors:  Shu-Chun Kuo; Shun-Hsing Hung; Hsien-Yi Wang; Chih-Chiang Chien; Chin-Li Lu; Hung-Jung Lin; How-Ran Guo; Jian-Fang Zou; Chian-Shiung Lin; Chien-Cheng Huang
Journal:  Asian J Androl       Date:  2013-10-14       Impact factor: 3.285

7.  Comparison of artificial neural network (ANN) and partial least squares (PLS) regression models for predicting respiratory ventilation: an exploratory study.

Authors:  Ming-I Brandon Lin; William A Groves; Andris Freivalds; Eun Gyung Lee; Martin Harper
Journal:  Eur J Appl Physiol       Date:  2011-08-23       Impact factor: 3.078

Review 8.  Critical review of prostate cancer predictive tools.

Authors:  Shahrokh F Shariat; Michael W Kattan; Andrew J Vickers; Pierre I Karakiewicz; Peter T Scardino
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

9.  [An artificial neural network as a tool in risk evaluation of prostate cancer. Indication for biopsy with the PSA range of 2-20 microg/l].

Authors:  C Stephan; B Vogel; H Cammann; M Lein; V Klevecka; P Sinha; G Kristiansen; D Schnorr; K Jung; S A Loening
Journal:  Urologe A       Date:  2003-03-22       Impact factor: 0.639

10.  Development and validation of risk score for predicting positive repeat prostate biopsy in patients with a previous negative biopsy in a UK population.

Authors:  Mark A Rochester; Nora Pashayan; Fiona Matthews; Andrew Doble; John McLoughlin
Journal:  BMC Urol       Date:  2009-07-16       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.